Literature DB >> 15235827

Effects of volatile anesthetics on cardiac metabolism in the low-pressure perfused rat heart.

S Kashimoto1, S Hinohara, T Kumazawa.   

Abstract

Effects of halothane, enflurane and isoflurane on the myocardial metabolism were studied in the rat heart-lung preparation. Hearts were perfused at a low perfusion pressure (SBP 50 mmHg, DBP 30 mmHg) with succinate or glutamate as substrates. Thirty minutes after the perfusion, intramyocardial ATP, pyruvate, lactate and glycogen were measured enzymatically. Although there was no significant difference in ATP levels of hearts with either substrate, and whether or not volatile anesthetics were present, 1% halothane and 1.5% isoflurane reduced the L/P ratio when succinate was substrate (24.46 +/- 4.81, 17.68 +/- 9.10 vs 39.82 +/- 10.83), and 2% enflurane decreased it when glutamate was substrate (22.25 +/- 10.99 vs 38.44 +/- 6.55). The glycogen levels in volatile anesthetics groups were lower than control when succinate was substrate. The improvement of energy demand-supply balance by inhalation anesthetics may be stronger than their inhibition of electron transport in mitochondria under certain ischemic conditions.

Entities:  

Year:  1988        PMID: 15235827     DOI: 10.1007/s0054080020012

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  24 in total

1.  [New values for the molar extinction coefficients of NADH and NADPH for the use in routine laboratories (author's transl)].

Authors:  H U Bergmeyer
Journal:  Z Klin Chem Klin Biochem       Date:  1975-11

2.  Action of halothane upon mitochondrial respiration.

Authors:  R A Harris; J Munroe; B Farmer; K C Kim; P Jenkins
Journal:  Arch Biochem Biophys       Date:  1971-02       Impact factor: 4.013

3.  The effect of halothane on electron transport, oxidative phosphorylation, and swelling in rat liver mitochondria.

Authors:  R N Miller; F E Hunter
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

4.  Is the rate-pressure product a misleading guide?

Authors:  I Kissin; J G Reves; M Mardis
Journal:  Anesthesiology       Date:  1980-04       Impact factor: 7.892

5.  The rate-pressure product in clinical anesthesia: boon or bane?

Authors:  P G Barash; C J Kopriva
Journal:  Anesth Analg       Date:  1980-04       Impact factor: 5.108

6.  Changes in canine myocardial blood flow and oxygen consumption in response to halothane.

Authors:  G Smith; J P Vance; D M Brown; J C McMillan
Journal:  Br J Anaesth       Date:  1974-11       Impact factor: 9.166

7.  Halothane and the beating response and ATP turnover rate of heart cells in tissue culture.

Authors:  L J Stong; C R Hartzell; R L McCarl
Journal:  Anesthesiology       Date:  1975-02       Impact factor: 7.892

8.  Effect of halothane on contractile function of ischemic myocardium.

Authors:  I Kissin; C T Thomson; L R Smith
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

9.  Regional ischemic ventricular dysfunction in myocardium supplied by a narrowed coronary artery with increasing halothane concentration in the dog.

Authors:  E Lowenstein; P Foëx; C M Francis; W L Davies; S Yusuf; W A Ryder
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

10.  Halothane improves the balance of oxygen supply to demand in acute experimental myocardial ischaemia.

Authors:  G Smith; K Rogers; J Thorburn
Journal:  Br J Anaesth       Date:  1980-06       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.